An External Control Arm Study in Non-Small Cell Lung Cancer
Recruiting now
Conditions studied: Non Small Cell Lung Cancer
In brief
A study to create control arms using current and future information in patients with lung cancer.
Key facts
- Study ID
- NCT07174388
- Run by
- N-Power Medicine
- People needed
- 650
- Starts
- 2026-01-07
- Expected to finish
- 2029-04-01
- Last updated by the study team
- 2026-06-16
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- > 18 years of age at the time of informed consent
- Pathologically confirmed locally advanced or metastatic NSCLC
- ECOG Performance of less than or equal to 1 within 4 weeks prior to starting index therapy.
- Life expectancy of more than 3 months
- Able to understand and sign informed consent
- Evidence of measurable disease (as assessed by the Investigator) on available imaging (e.g CT, MRI, PET)
- see protocol for cohort specific inclusion criteria*
You may not qualify if…
- Actively on a clinical trial of an investigational agent
- Currently receiving active systemic therapy for another malignancy
- Eligible for treatment with curative intent
- see protocol for cohort specific exclusion criteria*
Where it is running
- Pacific Cancer Care — Monterey, California, United States (enrolling)
- Bayhealth Medical Center, Kent Campus — Dover, Delaware, United States (enrolling)
- Bayhealth Medical Center- Sussex Campus — Milford, Delaware, United States (enrolling)
- Northwest Oncology and Hematology — Barrington, Illinois, United States (enrolling)
- Northwest Oncology and Hematology — Elk Grove, Illinois, United States (enrolling)
- Northwest Oncology and Hematology — Hoffman Estates, Illinois, United States (enrolling)
- Northwest Oncology and Hematology — Rolling Meadows, Illinois, United States (enrolling)
- Oncology Consultants — Houston, Texas, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.